Dr Agarwals Healthcare IPO
- IPO Date29 Jan, 2025 to 31 Jan, 2025
- Listing Date05 Feb, 2025
- Face Value₹1 per share
- Issue Price₹382 to ₹402 per share
- Lot Size35 Shares
- Minimum Investment₹14,070
- Listing AtBSE, NSE
- Total Issue Size7,53,04,970 Shares
(aggregating up to ₹3027.26 Cr) - Fresh Issue74,62,686 Shares
(aggregating up to ₹300.00 Cr)
- Offer for Sale6,78,42,284 Shares
(aggregating up to ₹2727.26 Cr) - Issue TypeBook Built Issue IPO
- Share holding pre issue30,84,17,160
- Shareholding post issue31,58,79,846
IPO Dates
Closing Date
31 Jan, 2025
Initiation of Refunds
04 Feb, 2025
Listing Date
05 Feb, 2025
29 Jan, 2025
Opening Date
03 Feb, 2025
Basis of Allotment
04 Feb, 2025
Credit of Shares
Dr Agarwals Healthcare Lot Size
Investors can bid for a minimum of 35 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| S-HNI (Min) | 15 | 525 | ₹2,11,050 |
| Retail (Min) | 1 | 35 | ₹14,070 |
| B-HNI (Min) | 72 | 2520 | ₹10,13,040 |
| S-HNI (Max) | 71 | 2485 | ₹9,98,970 |
| Retail (Max) | 14 | 490 | ₹1,96,980 |
Dr Agarwals Healthcare Promoter Holding
The Promoters of the Company are Dr. Amar Agarwal, Dr. Athiya Agarwal, Dr Adil Agarwal, Dr. Anosh Agarwal, Dr Ashvin Agarwal, Dr. Ashar Agarwal, Dr. Amar Agarwal Family Trust, Dr Adil Agarwal Family Trust, Dr. Anosh Agarwal Family Trust, Dr Ashvin Agarwal Family Trust, Dr. Ashar Agarwal Family Trust, Dr Agarwal’s Eye Institute and Dr Agarwal's Eye Institute Private Limited
| Pre Issue Share Holding | Post Issue Share Holding |
|---|---|
| 37.72% | - |
Dr Agarwals Healthcare COMPANY INFORMATION
Dr Agarwals Healthcare IPO is a book built issue of Rs 3,027.26 crores. The issue is a combination of fresh issue of 0.75 crore shares aggregating to Rs 300.00 crores and offer for sale of 6.78 crore shares aggregating to Rs 2,727.26 crores. Dr Agarwals Healthcare IPO opens for subscription on January 29, 2025 and closes on January 31, 2025. The allotment for the Dr Agarwals Healthcare IPO is expected to be finalized on Monday, February 3, 2025. Dr Agarwals Healthcare IPO will list on BSE, NSE with tentative listing date fixed as Wednesday, February 5, 2025. Dr Agarwals Healthcare IPO price band is set at ₹382 to ₹402 per share. The minimum lot size for an application is 35. The minimum amount of investment required by retail investors is ₹14,070. The minimum lot size investment for sNII is 15 lots (525 shares), amounting to ₹2,11,050, and for bNII, it is 72 lots (2,520 shares), amounting to ₹10,13,040. Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Pvt Ltd, Jefferies India Private Limited, Motilal Oswal Investment Advisors Limited are the book running lead managers of the Dr Agarwals Healthcare IPO, while Kfin Technologies Limited is the registrar for the issue.
Incorporated in 2010, Dr. Agarwal's Health Care offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.
As of September 30, 2024, there were 737 doctors providing care to patients across the company's facilities. During this period, the company served 2.13 million patients and performed 220,523 surgeries. In the six months leading up to September 30, 2024, they served 1.15 million patients and conducted 140,787 surgeries.
The Services provided by the company are:-
Cataract surgeries Offer cataract surgical treatments at its Facilities, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery and glued intraocular lens treatments;
Refractive surgeries: Refractive surgeries are procedures that correct eye refractive errors, helping individuals reduce or eliminate their need for glasses and contact lenses. The main types include LASIK, SMILE, implantable collamer lenses, and photorefractive keratectomy (PRK).
Other surgeries: Offer a range of other surgical treatments for eye ailments, such as surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty and surgeries for the treatment of glaucoma and pterygium.
As of September 30, 2024, the company's Indian network has 28 hubs (Tertiary Facilities, including three COEs) and 165 spokes (53 Primary and 112 Secondary Facilities).
As of September 30, 2024, the company has a presence in India across 117 metro and non-metro cities spanning 14 states and four union territories through 193 Facilities.
Competitive Strength
- Largest eye care services provider in India with a trusted brand
- End-to-end, comprehensive eye care services offering
- Scalable, asset-light, hub-and-spoke operating model
- Proven clinical excellence is driven by a strong clinical board and a history of surgical innovations.
- Doctor-promoters leading a team of qualified medical professionals and supported by experienced management
- Proven track record of delivering organic growth, integrating and scaling acquisitions and improving operating profitability
Dr. Agarwal’s Health Care IPO
IPO Overview and Key Highlights
Dr. Agarwal’s Health Care, a Chennai-based company specializing in comprehensive eye care solutions, is offering its Initial Public Offering (IPO). The IPO comprises a fresh issue of up to ₹3,000 million in equity shares and an Offer for Sale (OFS) of 67,842,284 equity shares. The proceeds will be utilized for expansion, debt repayment, and corporate purposes. Shares will be listed on the NSE and BSE.
Key IPO Details
- Type of Issue: Book Built Issue
- Total Issue Size: ₹3,000 million (fresh issue) + Offer for Sale
- Face Value: ₹1 per share
- Offer Price: To be determined
- Offer Opens: January 29, 2025
- Offer Closes: January 31, 2025
- Listing Exchange: NSE and BSE
Company Overview
Incorporated in 2010, Dr. Agarwal’s Health Care is one of India’s largest eye care networks. It operates advanced eye hospitals and specialty clinics in India and abroad. Promoters include Dr. Amar Agarwal, Dr. Athiya Agarwal, and the Agarwal family trusts. The company has a strong reputation for offering innovative treatments like robotic surgeries, LASIK, and cataract procedures.
Financial Overview
The company has showcased robust financial growth driven by increasing demand for high-quality eye care services. The IPO proceeds will help further expansion and enhance infrastructure capabilities.
Key Strengths of Dr. Agarwal’s Health Care
- Leading Market Position: A trusted name in eye care with a vast network of hospitals.
- Innovation in Healthcare: Known for adopting cutting-edge medical technologies.
- Experienced Promoters: A strong leadership team with decades of medical expertise.
IPO Pros and Cons
Pros
- Growth Sector: Expanding healthcare needs in India and abroad.
- Proceeds Utilization: Funds for operational growth and reducing debt.
- Established Brand: Trusted reputation in the healthcare sector.
Cons
- Market Dependency: Revenue tied to healthcare spending trends.
- Competitive Landscape: Faces competition from other healthcare networks.
- Regulatory Challenges: Compliance with medical and ethical standards.
Risk Factors
Investors should consider the following risks:
- Economic Sensitivity: Revenue influenced by economic health and disposable income.
- Operational Challenges: Scaling up operations without compromising service quality.
- Regulatory Compliance: Adherence to stringent healthcare regulations.
Conclusion
The Dr. Agarwal’s Health Care IPO offers an opportunity to invest in a leading player in the healthcare industry. With its focus on innovation and expansion, the company is well-positioned for growth. However, investors should carefully assess risks related to market dependency, competition, and operational scalability before making an investment decision.
FAQs About Dr Agarwals Healthcare Ipo
Dr Agarwals Healthcare IPO will open on 29 Jan, 2025 and close on 31 Jan, 2025. Investors must apply within this period to participate.
The Dr Agarwals Healthcare IPO price band is set between ₹382.00 and ₹402.00 per share. The minimum lot size is 35, requiring an investment of at least ₹14070.00.
The Dr Agarwals Healthcare IPO shares are expected to be listed on 05 Feb, 2025, subject to regulatory approvals and final allotment.
You can track your Dr Agarwals Healthcare IPO application status on the registrar’s website: Link Intime or KFintech using your PAN, application number, or DP ID
The Dr Agarwals Healthcare IPO will be listed on major stock exchanges such as NSE and BSE, where you can trade shares once they are listed.